A new hand-held device uses lasers and sound waves to accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or prognosis. 

Melanoma is the fifth most common cancer type in the United States, and incidence rates are rising faster than those of any other cancer. It's also the deadliest form of skin cancer, causing more than 75 percent of skin-cancer deaths. The thicker the melanoma tumor, the more likely it will spread and the deadlier it becomes, says dermatologist Lynn Cornelius of
Washington University in St. Louis
, one of the study's coauthors. Being able to measure the depth of the tumor in vivo enables doctors to determine prognoses more accurately—potentially at the time of initial evaluation—and plan treatments and surgeries accordingly.

The problem is that current methods can't directly measure a patient's tumor very well. Because skin scatters light, high-resolution optical techniques don't reach deep enough. "None are really sufficient to provide the two to four millimeter penetration that's at least required for melanoma diagnosis, prognosis or surgical planning," says engineer and paper co-author Lihong Wang.




The handheld probe. The motor, translation stage, ultrasonic transducer, and optical fibers are all incorporated in this handheld probe for easy operation. Credit: Yong Zhou

Researchers have tried other methods, but they aren't much better. High-frequency ultrasound doesn't have enough image contrast, and magnetic resonance imaging and positron emission tomography have insufficient resolution and require expensive and bulky instruments.

"Any type of tissue diagnosis at this point in time requires taking tissue out of the person and processing it and looking at it under the microscope," Cornelius says.


But because taking a biopsy often only involves the removal of a part of a tumor—when it's in a cosmetically sensitive area, for instance—provisional measurements of the tumor depth are not always reliable. If, at the time of excision, the surgeon finds that the tumor goes deeper than initially thought, the patient may need yet another surgery.

Recently, researchers including Wang have applied an approach called photoacoustic microscopy, which can accurately measure melanoma tumors directly on a patient's skin—thus allowing doctors to avoid uncertainty in some circumstances.

The technique relies on the photoacoustic effect, in which light is converted into vibrations. In the case of the new device, a laser beam shines into the skin at the site of a tumor. Melanin, the skin pigment that's also in tumors, absorbs the light, whose energy is transferred into high-frequency acoustic waves. Unlike light, acoustic waves don't scatter as much when traveling through skin. Tumor cells will produce more melanin than the surrounding healthy skin cells, and as a result, the acoustic waves can be used to map the entire tumor with high resolution. The device has a detector that can then turn the acoustic signal into a three-dimensional image on a screen.

Wang, Cornelius and their colleagues previously built a similar desktop device, which shines the laser directly onto the tumor. But so much light is absorbed that very little penetrates to the tumor's lower layers. The latest version, however, is not only hand-held, but it also delivers light around and below the tumor, which generates a bright image of the tumor's bottom and an accurate measurement of its depth.

The researchers tested their device on both artificial tumors made of black gelatin and on real ones in live mice, showing that the instrument could accurately measure the depths of tumors—and do it in living tissue.

Initially, this tool will be mainly used for improving how doctors plan and prepare for surgeries, Cornelius says. But what's especially exciting, she adds, is that it can measure a tumor's entire volume—something that's never been possible with melanoma. If researchers can determine how the volume relates to cancer outcomes, then this tool could give doctors a new type of measurement for diagnosis and prognosis.

The researchers are now conducting further tests with human patients. The new device will have to prove effective in clinical trials before it is widely available. But other than that Wang says, the device is essentially ready for commercialization.



 Published in Optics Letters,
Source: The Optical Society